Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$910M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$449M |
| 5 |
Itaú Unibanco
ITUB
|
+$409M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.25B |
| 2 |
Canadian Natural Resources
CNQ
|
+$897M |
| 3 |
Enbridge
ENB
|
+$555M |
| 4 |
Suncor Energy
SU
|
+$483M |
| 5 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.5% |
| 2 | Healthcare | 8.63% |
| 3 | Financials | 8.23% |
| 4 | Consumer Discretionary | 7.29% |
| 5 | Industrials | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Adaptive Biotechnologies
ADPT
$3.88B
| $13.2M | ﹤0.01% |
1,499,737
+209,162
| +16% | +$1.84M |
|
2152
Denali Therapeutics
DNLI
$3.91B
| $13.2M | ﹤0.01% |
572,843
-198,609
| -26% | -$5.47M |
|
2153
Teradata
TDC
$2.55B
| $13.2M | ﹤0.01% |
327,102
-298,925
| -48% | -$11.1M |
|
2154
Krispy Kreme
DNUT
$572M
| $13.1M | ﹤0.01% |
844,716
-165,738
| -16% | -$2.15M |
|
|
SNV
2155
DELISTED
Synovus
SNV
| $13.1M | ﹤0.01% |
425,759
-1,553,493
| -78% | -$59.2M |
|
2156
Roivant Sciences
ROIV
$26B
| $13.1M | ﹤0.01% |
1,775,191
+1,253,849
| +241% | +$10.3M |
|
2157
Cracker Barrel
CBRL
$1.29B
| $13.1M | ﹤0.01% |
114,965
-9,463
| -8% | -$1.03M |
|
2158
PUT
Moderna
MRNA
$22.8B
| $13.1M | ﹤0.01% |
85,000
-150,300
| -64% | -$24.8M |
|
2159
PUT
iShares MSCI Turkey ETF
TUR
$213M
| $13M | ﹤0.01% |
+400,000
| New | +$13.8M |
|
2160
Brink's
BCO
$4.67B
| $13M | ﹤0.01% |
195,250
-55,427
| -22% | -$3.52M |
|
2161
Upstart Holdings
UPST
$2.96B
| $13M | ﹤0.01% |
818,951
-16,480
| -2% | -$277K |
|
2162
National Vision
EYE
$1.81B
| $13M | ﹤0.01% |
690,707
-39,840
| -5% | -$1.3M |
|
2163
State Street SPDR S&P Pharmaceuticals ETF
XPH
$507M
| $13M | ﹤0.01% |
317,137
+50,437
| +19% | +$2.12M |
|
2164
PUT
SLB Ltd
SLB
$76B
| $13M | ﹤0.01% |
264,600
-193,900
| -42% | -$10.3M |
|
2165
ADT
ADT
$5.63B
| $13M | ﹤0.01% |
1,796,457
-107,036
| -6% | -$873K |
|
|
RETA
2166
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $13M | ﹤0.01% |
142,799
-130,419
| -48% | -$7.65M |
|
2167
Thor Industries
THO
$4.12B
| $13M | ﹤0.01% |
162,922
-107,606
| -40% | -$9.49M |
|
2168
Celldex Therapeutics
CLDX
$3.27B
| $13M | ﹤0.01% |
360,173
-89,411
| -20% | -$3.86M |
|
|
NTST
2169
NETSTREIT Corp
NTST
$2.13B
| $12.9M | ﹤0.01% |
707,170
+47,163
| +7% | +$910K |
|
|
HEES
2170
DELISTED
H&E Equipment Services
HEES
| $12.9M | ﹤0.01% |
291,547
-274,750
| -49% | -$13.4M |
|
2171
PUT
Cameco
CCJ
$41.6B
| $12.9M | ﹤0.01% |
+492,400
| New | +$13M |
|
2172
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $12.9M | ﹤0.01% |
121,159
+3,680
| +3% | +$402K |
|
2173
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.06B
| $12.8M | ﹤0.01% |
456,557
| – | – |
|
2174
Phreesia
PHR
$787M
| $12.8M | ﹤0.01% |
396,172
+105,653
| +36% | +$3.72M |
|
2175
Coursera
COUR
$1.53B
| $12.8M | ﹤0.01% |
1,109,986
+290,779
| +35% | +$3.76M |
|
Similar funds
Goldman Sachs's Q1 2023 Portfolio in Review
As of Q1 2023, Goldman Sachs held 6,534 positions worth $435B, up 6.7% from $408B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q1 2023 filing shows 572 new, 2,273 increased, 2,515 reduced and 647 closed positions. Its largest new stake was GE HealthCare: 1,100,798 shares worth $90.3M. The largest sale was Alibaba, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Goldman Sachs's largest Q1 2023 buy was GE HealthCare: 1,100,798 shares worth $90.3M.
- Goldman Sachs added most to Microsoft in Q1 2023, an estimated $1.15B increase.
- Goldman Sachs's biggest Q1 2023 reduction was Alibaba, cutting an estimated $1.25B.
- Goldman Sachs fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $122M.
- Goldman Sachs's ten largest holdings make up 18% of its $435B portfolio in Q1 2023.
- Goldman Sachs opened 572 new positions and closed 647 in Q1 2023.
- Goldman Sachs's portfolio value rose 6.7% quarter-over-quarter to $435B.
Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.